Drug Research
Drug Delivery

Drug Delivery

Sorrento acquires lymphatic delivery technology platform from Kimberly-Clark Sorrento Therapeutics has acquired Kimberly-Clark’s Sofusa lymphatic delivery technology platform for targeted biopharmaceuticals, particularly, the immune checkpoint inhibitors like anti-PD-1, CTLA4, CD47 antibodies and other I-O antibodies.
Drug Research > Drug Delivery > News
Novacap to acquire US-based CDMO PCI Synthesis Novacap has agreed to acquire Boston-based PCI Synthesis, a pharmaceutical contract development and manufacturing organization (CDMO), for an undisclosed price.
Drug Research > Drug Delivery > News Recipharm agrees to acquire Sanofi CMO business in UK Recipharm has agreed to acquire Sanofi CMO business in the UK for a consideration of £45m, in a bid to expand its inhalation capabilities.
Drug Research > Drug Delivery > News
See more Drug Delivery news

Latest Drug Delivery News and Insight